These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 31640628

  • 1. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
    Wittel UA, Lubgan D, Ghadimi M, Belyaev O, Uhl W, Bechstein WO, Grützmann R, Hohenberger WM, Schmid A, Jacobasch L, Croner RS, Reinacher-Schick A, Hopt UT, Pirkl A, Oettle H, Fietkau R, Golcher H.
    BMC Cancer; 2019 Oct 22; 19(1):979. PubMed ID: 31640628
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
    Bereska JI, Janssen BV, Nio CY, Kop MPM, Kazemier G, Busch OR, Struik F, Marquering HA, Stoker J, Besselink MG, Verpalen IM, Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortium.
    Eur Radiol Exp; 2024 Feb 12; 8(1):18. PubMed ID: 38342782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH, Ha HI, Jang JY, Lee JW, Choi JY, Bang S, Lee CH, Kim WB, Lee SS, Kim SC, Kang BK, Lee JM.
    Eur Radiol; 2023 Sep 12; 33(9):5965-5975. PubMed ID: 36988715
    [Abstract] [Full Text] [Related]

  • 6. Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging.
    Kunz JM, Maloca P, Allemann A, Fasler D, Soysal S, Däster S, Kraljević M, Syeda G, Weixler B, Nebiker C, Ochs V, Droeser R, Walker HL, Bolli M, Müller B, Cattin P, Staubli SM.
    Int J Comput Assist Radiol Surg; 2024 Sep 12; 19(9):1677-1687. PubMed ID: 38252362
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot.
    Pilgrim CHC, Maciejewska A, Ayres N, Ellis S, Goodwin M, Zalcberg JR, Haydon A.
    ANZ J Surg; 2022 Oct 12; 92(10):2565-2570. PubMed ID: 36054233
    [Abstract] [Full Text] [Related]

  • 10. Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study.
    van Veldhuisen E, Walma MS, van Rijssen LB, Busch OR, Bruijnen RCG, van Delden OM, Mohammad NH, de Hingh IH, Yo LS, van Laarhoven HW, van Leeuwen MS, Nio CY, van Santvoort HC, de Vries J, Wessels FJ, Wilmink JW, Molenaar IQ, Besselink MG, van Lienden KP, Dutch Pancreatic Cancer Group.
    HPB (Oxford); 2019 Oct 12; 21(10):1385-1392. PubMed ID: 31010633
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB.
    Dan Med J; 2012 Dec 12; 59(12):B4568. PubMed ID: 23290296
    [Abstract] [Full Text] [Related]

  • 15. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT.
    Morgan DE, Waggoner CN, Canon CL, Lockhart ME, Fineberg NS, Posey JA, Vickers SM.
    AJR Am J Roentgenol; 2010 Mar 12; 194(3):615-22. PubMed ID: 20173136
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
    Hong SB, Lee SS, Kim JH, Kim HJ, Byun JH, Hong SM, Song KB, Kim SC.
    Radiology; 2018 Dec 12; 289(3):710-718. PubMed ID: 30251929
    [Abstract] [Full Text] [Related]

  • 17. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
    Vullierme MP, Giraud-Cohen M, Hammel P, Sauvanet A, Couvelard A, O'Toole D, Levy P, Ruszniewski P, Vilgrain V.
    Radiology; 2007 Nov 12; 245(2):483-90. PubMed ID: 17848678
    [Abstract] [Full Text] [Related]

  • 18. Selection criteria in resectable pancreatic cancer: a biological and morphological approach.
    Tamburrino D, Partelli S, Crippa S, Manzoni A, Maurizi A, Falconi M.
    World J Gastroenterol; 2014 Aug 28; 20(32):11210-5. PubMed ID: 25170205
    [Abstract] [Full Text] [Related]

  • 19. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey.
    Badgery HE, Muhlen-Schulte T, Zalcberg JR, D'souza B, Gerstenmaier JF, Pickett C, Samra J, Croagh D, Pancreatic Cancer Image Biobank Authorship Group.
    HPB (Oxford); 2023 Nov 28; 25(11):1393-1401. PubMed ID: 37558564
    [Abstract] [Full Text] [Related]

  • 20. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society.
    Yamada S, Fujii T, Takami H, Hayashi M, Iwata N, Kanda M, Tanaka C, Sugimoto H, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    Surgery; 2017 Oct 28; 162(4):784-791. PubMed ID: 28655416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.